InnovAge Financial Ratios
NASDAQ: INNVHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
InnovAge ratio analysis
InnovAge earned a net margin of -0.3% in FY 2026, up from -3.6% a year earlier. Gross margin was 23.0% compared with a median of 17.6% over the prior 4 years. Return on equity reached -1.1%, meaning InnovAge generated -0.01 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.20 versus 0.25 the year before, and the current ratio was 1.05. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
InnovAge financial ratios (annual)
| Ratio | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Price / sales | 1.64 | 0.71 | 0.88 | 1.48 | 0.86 | 4.18 | — |
| Price / book | 6.91 | 2.57 | 2.50 | 3.43 | 1.81 | 7.97 | — |
| Gross margin | 23.0% | 18.0% | 17.3% | 14.7% | 19.4% | — | — |
| Operating margin | 0.3% | -3.5% | -3.0% | -7.2% | -0.6% | -1.9% | 9.0% |
| Net margin | -0.3% | -3.6% | -2.8% | -5.9% | -0.9% | -6.9% | 4.6% |
| Free cash flow margin | 5.1% | 3.1% | -5.9% | -0.5% | -1.6% | -3.9% | 5.6% |
| Return on equity (ROE) | -1.1% | -12.9% | -7.9% | -13.7% | -2.0% | -13.1% | 26.0% |
| Return on assets (ROA) | -0.5% | -5.8% | -3.9% | -7.2% | -1.2% | -8.3% | 6.4% |
| Debt / equity | 0.20 | 0.25 | 0.24 | 0.23 | 0.22 | 0.23 | 2.10 |
| Current ratio | 1.05 | 1.07 | 1.25 | 1.45 | 2.29 | 3.19 | 2.18 |
| Revenue growth | 15.9% | 11.8% | 11.0% | -1.5% | 9.5% | 12.4% | — |
| EPS growth | — | — | — | — | — | -289.5% | — |